AGF Investments LLC’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.64M Buy
13,358
+6,707
+101% +$883K 0.15% 55
2022
Q2
$884K Buy
6,651
+360
+6% +$49.1K 0.08% 182
2022
Q1
$861K Buy
6,291
+901
+17% +$126K 0.07% 147
2021
Q4
$933K Buy
5,390
+1,290
+31% +$196K 0.08% 61
2021
Q3
$596K Sell
4,100
-534
-12% -$78.1K 0.06% 156
2021
Q2
$612K Buy
+4,634
New +$607K 0.06% 149
2021
Q1
Sell
-88
Closed -$10K 447
2020
Q4
$10K Sell
88
-31
-26% -$3.78K ﹤0.01% 466
2020
Q3
$14K Hold
119
﹤0.01% 459
2020
Q2
$14K Sell
119
-7,098
-98% -$753K ﹤0.01% 490
2020
Q1
$580K Sell
7,217
-1,026
-12% -$106K 0.08% 237
2019
Q4
$880K Buy
8,243
+3,730
+83% +$389K 0.16% 212
2019
Q3
$483K Buy
4,513
+1,343
+42% +$138K 0.11% 204
2019
Q2
$323K Buy
3,170
+576
+22% +$55.4K 0.07% 242
2019
Q1
$233K Buy
2,594
+2,544
+5,088% +$220K 0.05% 231
2018
Q4
$4K Sell
50
-50
-50% -$4.69K ﹤0.01% 644
2018
Q3
$11K Buy
100
+50
+100% +$5.48K ﹤0.01% 631
2018
Q2
$6 Sell
50
-6
-11% -$625 ﹤0.01% 735
2018
Q1
$6K Hold
56
﹤0.01% 556
2017
Q4
$6K Buy
+56
New +$5.31K ﹤0.01% 663
2017
Q3
Sell
-86
Closed -$10K 770
2017
Q2
$10K Sell
86
-12
-12% -$1.27K ﹤0.01% 493
2017
Q1
$10K Sell
98
-10
-9% -$953 ﹤0.01% 493
2016
Q4
$10K Buy
+108
New +$9.31K ﹤0.01% 585

Other funds holding DGX

AGF Investments LLC's DGX Position: Q3 2022 in Review

AGF Investments LLC increased its Quest Diagnostics (DGX) stake by 101% in Q3 2022, buying an estimated $883K and bringing the position to 13,358 shares worth $1.64M. The position accounts for 0.15% of the portfolio, ranked #55.

AGF Investments LLC first reported a position in DGX in Q4 2016 and has held it in 22 quarters since. 809 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • AGF Investments LLC held 13,358 shares of Quest Diagnostics worth $1.64M as of Q3 2022.
  • AGF Investments LLC bought 6,707 Quest Diagnostics shares in Q3 2022, an estimated $883K.
  • Quest Diagnostics made up 0.15% of AGF Investments LLC's portfolio in Q3 2022, its #55 holding.
  • AGF Investments LLC first reported a position in Quest Diagnostics in Q4 2016 and has held it in 22 quarters since.
  • 809 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.